سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

A Validated and Rapid HPLC Method for Quantification of Human Serum Albumin in Interferon beta-1a Biopharmaceutical Formulation

Publish Year: 1396
Type: Journal paper
Language: English
View: 505

This Paper With 5 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_MBT-1-1_004

Index date: 30 May 2020

A Validated and Rapid HPLC Method for Quantification of Human Serum Albumin in Interferon beta-1a Biopharmaceutical Formulation abstract

Multiple sclerosis, or MS, is a long-lasting disease that can affect your brain, spinal cord, and the optic nerves in your eyes. It can cause problems with vision, balance, muscle control, and other basic body functions. IFN-beta treatment reduces the relapse rate in multiple sclerosis (MS), but the exact mechanism of action of the drug has remained elusive. CD73 (ecto-5 -nucleotidase) is an ectoenzyme, which produces adenosine from adenosine monophosphate (AMP) precursor by enzymatic dephosphorylation. In this study, a validated and rapid HPLC method for quantification of human serum albumin in interferon beta-1a biopharmaceutical formulation was developed and linearity, robustness, specificity, accuracy and precision of samples were determined.

A Validated and Rapid HPLC Method for Quantification of Human Serum Albumin in Interferon beta-1a Biopharmaceutical Formulation Keywords:

A Validated and Rapid HPLC Method for Quantification of Human Serum Albumin in Interferon beta-1a Biopharmaceutical Formulation authors

Somayyeh Heidary

Department of Cell and Molecular Biology, Universiti Putra Malaysia, Serdang, Malaysia

Mohsen Imani

Cinnagen Pharmaceutical Company, Karaj, Iran

Seyed Mojtaba Mostafavi

ACROSS ​Centre (Australian Centre for Research on Separation Science) University of Tasmania Hobart​, Australia